Skip to main content
. Author manuscript; available in PMC: 2018 May 25.
Published in final edited form as: Adv Funct Mater. 2017 Mar 23;27(20):1606506. doi: 10.1002/adfm.201606506

Figure 6.

Figure 6

Drain current change of anti-GFAP modified devices (a) in 0.05X PBS for 30 min; (b) after 100 ng/mL PBP2a; (c) after 100 ng/mL 17α-OHP; (d) after the mixed solution (composed of 100 ng/mL PBP2a, 100 ng/mL 17α-OHP and 100 ng/mL GFAP) dropped on the anti-GFAP modified device.